Nine months: Weight loss continues but tends to slow down, potentially even plateauing for a while
The different receptor profiles may activate pathways that had become less responsive to single-target therapy
Whether it pays off in the populations not yet read out type 2 diabetes (TRIUMPH-2), sleep apnea (TRIUMPH-3), cardiovascular outcomes (TRIUMPH-CVOT) is the next set of questions
GLP-1 therapies improve endothelial signaling, which enhances nitric oxide production
Keeps your skin moisturized even after cleansing by strengthening the skin moisture barrier
Dietitians can embrace weight management medications as a helpful element of successful short- and long-term management of type 2 diabetes, excess weight, CVD, and potentially other comorbidities